NL-OMON37072已完成不适用
Pharmacokinetics of Levosimendan in Children with Acute Heart Failure - LevoCorKids
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •Children < 16 years of age with heartfailure admiited to the pediatric intensive care and who will recieve levosimendan as part of their treatment.
- •Informed consent from parents
排除标准
- •No informed consent.
- •Contraindications for levosimendan (arrhytmias, hypotension)
- •No sampling line
研究者
相似试验
进行中（未招募）
1 期
How does the body of children deal with Levosimendan, a drug which strengthens the heart.heart failureEUCTR2012-000588-26-FIeiden University Medical Center36
进行中（未招募）
不适用
What are the blood levels of Levosimendan in children treated for heart failure?Acute heart failure in childrenEUCTR2012-000588-26-NLeiden University Medical Center
已完成
不适用
Pharmacokinetics of Levosimendan in Pediatric Intensive Care UnitsAcute Heart FailureNCT03681379Nantes University Hospital27
招募中
1 期
Effects of Levosimendan in patients being weaned from venoarterial extracorporal membrane oxygenation. A randomized controlled investigator driven phase II trialCardiogenic ShockCTIS2023-508024-36-00Allgemeines Krankenhaus Der Stadt Wien Universitatskliniken46
Unknown
不适用
Levosimendan Pharmacokinetics in ChildrenAcute Heart FailureNCT01704131Leiden University Medical Center36